The platform shows you where to launch
We make sure you get there
Dot IO Health is Adelo’s in-house consulting firm — and the strategy engine behind every launch we support. Medical communications, HCP engagement strategy, and pharmaceutical launch execution, backed by the full Adelo intelligence platform.
We work alongside agencies. Not against them.
dot io health
A boutique consulting team inside adelo
Fifteen years. Global top-20 pharma. Fast-growing biotechs. Data-connected launch strategies that most of the industry is only now catching up to. Dot IO Health is where the platform expertise meets the strategic experience.
We work alongside agencies. Not against them. If you’re a med comms agency and need strategic firepower on a specific brief, Dot IO Health is a resource you can call on — not a competing route to your client.
THE HONEST CASE FOR CONSULTING
Why more than half of drug launches miss their targets
It isn’t the molecule. It rarely is. It’s the gap between what the clinical trial proves and what the commercial strategy assumes. Field strategies built on convention. Markets prioritised by relationships. Payer positioning built without community-level patient data.
Dot IO Health closes that gap. Every engagement we design is informed by Adelo’s intelligence platform — geomapping, session data, SDOH analysis, prescribing patterns — before we recommend anything. We don’t just tell you what the data says. We help you act on it.
Five practice areas
One intelligence platform behind all of them
What we deliver
Medical Communications
Scientific narratives, publication strategy, and HCP education programmes built from real audience intelligence. We know what your HCPs are responding to — because we’ve been in the room and reading the signals.
HCP Engagement & KOL Strategy
Advisory board design, KOL mapping, speaker programme strategy. Every recommendation is grounded in Adelo session intelligence and geographic data — not instinct.
Market Access & Launch Strategy
Payer positioning and commercial launch support built around SDOH-informed market analysis. We show you where the barriers actually are — before you find out during launch.
Research & Real-World Evidence
Market research, advisory board intelligence, and RWE support — faster, deeper, and more actionable than standard agency research, because it’s built on a real intelligence platform.
Persona Intelligence & Session Analysis
We automatically generate belief-based HCP personas from event engagement signals, translating them into targeted messaging, territory plans, and speaker strategies.
From advisory board to published manuscript. We own the process.
Three principles
Every engagement
How we work
Intelligence first.
We start with your data — Adelo geomapping and SDOH analysis, your session archive, prescribing patterns, community health signals — before we make a single recommendation.
Strategy from evidence
Programmes designed around what the intelligence tells us, not what worked on a different asset for a different company last year.
Measure and compound
We deliver the programme, measure what changed, and feed the results back into the intelligence layer. Every engagement makes the next one better informed.
our work
What we've done
We work with the world’s largest pharmaceutical companies. We don’t name them publicly. But the work stands for itself.
SDOH Mapping — Global Top-10 Pharma
Pre-Phase III readout mapping of community-level patient burden, SDOH barriers, and KOL landscape across the US, UK, and Europe. Informed payer positioning and commercial launch sequencing before the asset reached market.
Global HCP Alignment — HIV Franchise
Aligned local HCP engagement strategy with global brand direction across Canada, the US, and the UK. Advisory board design, KOL profiling, and data-informed territory planning across three markets simultaneously.
Cardiovascular Publication Programme
leadership
The people behind the strategy
Nigel Breakwell
Managing Director, Dot IO Health
Biological sciences background. Career built across medical communications, HCP engagement, and data science-driven commercial strategy. Previously Group Director at WCG — launched the London office, grew the healthcare practice to $6M revenue across global clients. Before that, Interim Head of Healthcare at MS&L.
Serves on the Executive Committee of the Arrhythmia Alliance and Chairs its US Board of Directors, working to reduce sudden cardiac death and AF-related stroke.
Download
More than half of drug launches miss their revenue targets
This report explains why — and what changes the odds
Covers the commercial mechanics of health launches, why intelligence matters most in years 1–2, and how Dot IO Health uses Adelo’s platform to close the strategy-execution gap.
Name, email, and company required. One email only.
FAQS
Consulting Common Questions
What is Dot IO Health?
Dot IO Health is adelo’s in-house consulting firm and strategy engine behind every launch adelo supports. It covers medical communications, HCP engagement strategy and pharmaceutical launch execution, backed by the full adelo intelligence platform.
Does Dot IO Health compete with medcomms agencies?
No. Dot IO Health works alongside agencies, not against them. If an agency needs strategic firepower on a specific brief, Dot IO Health is a resource to call on, not a competing route to the client.
Why do more than half of drug launches miss their targets?
It usually isn’t the molecule. It’s the gap between what the clinical trial proves and what the commercial strategy assumes, field strategies built on convention, markets prioritised by relationships, and payer positioning built without community-level patient data. Dot IO Health closes that gap using adelo’s geomapping, session data and SDOH analysis before recommending anything.
What practice areas does Dot IO Health cover?
Five practice areas run on one intelligence platform: Medical Communications, HCP Engagement & KOL Strategy, Market Access & Launch Strategy, Research & Real-World Evidence, and Persona Intelligence & Session Analysis.
How does Dot IO Health approach a consulting engagement?
Three principles guide every engagement. Intelligence first, starting with adelo’s geomapping, SDOH analysis, session archive and prescribing patterns before any recommendation. Strategy from evidence, designing programmes around what the intelligence shows rather than what worked for a different asset last year. Measure and compound, feeding results from every engagement back into the intelligence layer so the next one is better informed.
